Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Dir DP until

NAV on April 25, 2024
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 879 cr
Turnover Ratio 23.30%
Expense Ratio 0.83%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: 1.62%
  • 1Y: 55.33%
  • 3M: 6.86%
  • 3Y: 18.16%
  • 6M: 28.39%
  • 5Y: 23.96%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since about 3 years)
ISIN INF277K011B8
Fund Family Tata
P/E Ratio 36.87
P/B Ratio 4.94
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 5.00
Beta 0.90
R-Squared 90.47
Info Ratio 0.96
Tracking Err 4.85
Sortino 1.941
Sharpe 1.023
Std Dev 14.861
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 1.87%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 98.13%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

This fund may declare and pay out a dividend to you on a periodic basis, but only when it has the profits to do so.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
388.458 55.57% 2,626 cr 0.95% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata